Bextra and Celebrex Settlement
Sign up for our newsletter to get updates on drugs & medical devices
If you would like to sign up for our newsletter click the button below.
$894 Million Dangerous Drug Settlement
In 2008, Pfizer announced plans to pay $894 million to settle claims over drug injuries caused by its arthritis medications, Bextra and Celebrex. The settlement included $745 million for personal injury claims, $60 million to settle improper marketing claims with several states and $89 million to settle class action lawsuits for consumer fraud related to promotional materials.
In September 2009, Pfizer also agreed to pay $2.3 billion to settle a U.S. Department of Justice investigation regarding the marketing of Bextra and other Pfizer drugs. Additionally, in 2016, Pfizer announced a settlement of $486 million for shareholders who claimed that the company had concealed the risks of Bextra, resulting in financial losses for its stock.
Due to the high rate of drug injuries, Bextra was withdrawn from the market only a few months after its approval and the U.S. Food and Drug Administration began requiring “black box warnings” on Celebrex due to a risk of cardiac events.
You May Be Eligible for Compensation.
If you or a loved one suffered injury or death after using a drug or medical device, contact us today for a free case evaluation.
Sign up for our newsletter here.
Enter your email to get updates from Drugdangers